| | Cancer | Skin Cancer
Non-Melanoma Skin Cancer Statistics: Incidence, Underreporting & Global Burden
Correction: Non-melanoma skin cancers (NMSC)—basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—are recorded in cancer statistics, but systematic underreporting obscures true incidence.
Epidemiologic Reality
- Most common cancer globally: NMSC exceeds all other cancers combined.
- Estimated annual cases: 5–7 million worldwide (BCC ~75%, SCC ~25%).
- Underreporting drivers:
- Mandatory reporting exemptions in many registries (low mortality).
- Outpatient treatment (destruction, excision) without pathology registry linkage.
- Multiple primaries per patient counted as single case.
- No centralized registry in many countries.
Regional Variation
- Highest: Australia, New Zealand, US (white populations), South Africa.
- Rising: Europe, Latin America, Asia (aging, UV exposure, detection).
- Mortality: Low (~0.5% of cancer deaths) but significant morbidity and cost.
Risk Factors
- Cumulative UV exposure (occupational, recreational).
- Fair skin (Fitzpatrick I–II), immunosuppression.
- Prior NMSC (35–50% 5-year recurrence risk).
- Genetic syndromes (xeroderma pigmentosum, basal cell nevus syndrome).
Public Health Implication
True NMSC burden is 2–5× reported rates. Prevention (UV protection, nicotinamide for high-risk) and registry reform are priorities. BCC rarely metastasizes; SCC has 2–5% metastatic potential—early detection critical.
Skin Cancer - Related Articles
- Tanning Bed Risks: Understanding the Dangers to Your Skin and Health
- Understanding Topical Chemotherapy Side Effects: What to Expect
- Melanoma Origins: From Melanocytes to Malignancy
- Skin Cancer Treatment: Options & What to Expect
- Understanding Skin Cancer: Prevention & Early Detection
- Recurrent Melanoma Treatment: Understanding Options & Improving Outcomes
- Serosa: Structure, Locations, and Functions of the Body's Serous Membranes
